trial

Brain Biomarker on Inflammation Response

NCTId NCT03271814
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 1 · Withdrawn
Enrollment 0 (actual)
Sponsored by University of Maryland, Baltimore County
Primary completion 2025-12-15
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 1
Status
Withdrawn
Enrollment
0 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Triple
Start
2025-01-01
Primary completion
2025-12-15
Eligibility
ALL · 15 Years · 55 Years

Interventions & indications

Drugs
LPS

Sponsors

University of Maryland, Baltimore CountyLead Sponsor

Investigators

1
L. Elliot Hong, M.D.Principal Investigator

Sites

0 total

Facts & assertions

4 sourced
Enrollment
0
Phase
PHASE1
Primary Completion Date
2025-12-15
Status
WITHDRAWN
relationships
The graph out of here
drug
LPS
drug
lead_sponsor
University of Maryland, Baltimore County
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
L. Elliot Hong, M.D.
person